Frier Levitt co-founding partner Jonathan Levitt has been featured in a Bloomberg Law article, “Employers Mourn Loss of Drug Data Transparency in Stopgap Bill” by Lauren Clason. The piece details the stopgap spending bill, which was recently unveiled by House lawmakers. The original language of the bill would have required extensive data reporting from PBMs and insurance companies to employers, including information on pricing, usage, distribution, and rebates for prescription drugs. The bill was intended to reform PBMs and the legal landscape around drug pricing. However, this language was ultimately dropped due to House Republicans’ need to meet demands from President-elect Donald Trump.
The article further sheds light on real world impacts from this development and examines how the original bill would have affected PBMs and employers, which Jonathan comments on throughout the story. Read the article along with all of Jonathan’s insights here: https://news.bloomberglaw.com/daily-labor-report/employers-mourn-loss-of-drug-data-transparency-in-stopgap-bill